SKIN

The Beauty Health Company NASDAQ

Consumer Defensive ·Household & Personal Products ·US · beautyhealth.com

$0.90

Pre-mkt $0.88 -2.20%

Mkt Cap $116.6M

52w Low $0.76 7.4% of range 52w High $2.69

50d MA $0.98 200d MA $1.47

P/E (TTM) -10.8x

EV/EBITDA 9747.5x

P/B 1.8x

Debt/Equity 6.2x

ROE -15.6%

P/FCF 4.7x

RSI (14) —

ATR (14) —

Beta 1.24

50d MA $0.98

200d MA $1.47

Avg Volume 733.2K

About

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 12, 2026	AMC	-0.07	-0.06	+14.3%	1.06	+6.6%	+19.8%	+13.2%	+10.4%	+11.3%	+9.4%	—
Nov 6, 2025	AMC	-0.08	-0.09	-12.5%	1.29	+6.2%	+8.5%	+7.0%	+1.6%	+3.1%	+0.8%	—
Aug 7, 2025	AMC	-0.06	0.03	+150.0%	1.59	+27.0%	+18.9%	+39.0%	+45.9%	+49.7%	+36.5%	—
May 8, 2025	AMC	-0.13	-0.08	+38.5%	1.24	+13.7%	+50.8%	+41.9%	+18.5%	+19.4%	+39.5%	—
Mar 12, 2025	AMC	-0.10	-0.08	+20.0%	1.42	-9.9%	-5.6%	-7.0%	-7.0%	-9.9%	-7.0%	—
Nov 12, 2024	AMC	-0.12	-0.15	-25.0%	1.70	+2.9%	+8.8%	+5.3%	-10.0%	-7.6%	-4.7%	—
Aug 8, 2024	AMC	-0.05	-0.10	-100.0%	1.29	-22.5%	-13.2%	+0.0%	-2.3%	+0.0%	+8.5%	—
May 9, 2024	AMC	-0.14	-0.10	+28.6%	3.59	-10.9%	-23.7%	-23.7%	-22.0%	-22.8%	-22.8%	—
Mar 12, 2024	AMC	-0.11	-0.07	+36.4%	3.59	+27.3%	+18.4%	+6.4%	+0.6%	+0.6%	+9.7%	—
Nov 13, 2023	AMC	0.04	0.05	+17.6%	3.90	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%	—
Aug 9, 2023	AMC	0.05	0.07	+40.0%	7.12	+1.8%	-0.6%	-1.8%	-7.9%	-13.3%	-15.3%	—
May 10, 2023	AMC	-0.02	-0.04	-80.1%	10.26	+0.5%	+4.2%	+1.8%	+7.0%	-1.7%	+1.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 16	TD Cowen	Maintains	Hold → Hold	—	$1.27	$1.30	+2.4%	-5.5%	-7.9%	-7.1%	-8.7%	-11.0%
Mar 13	Canaccord Genuity	Maintains	Hold → Hold	—	$1.06	$1.13	+6.6%	+19.8%	+13.2%	+10.4%	+11.3%	+9.4%
Jan 21	TD Cowen	Maintains	Hold → Hold	—	$1.44	$1.44	+0.0%	+6.9%	+8.3%	+6.2%	+5.6%	+5.6%
Sep 22	TD Cowen	Maintains	Hold → Hold	—	$2.28	$2.27	-0.4%	+0.0%	-4.4%	-10.1%	-14.9%	-13.6%
Aug 1	Stifel	Maintains	Hold → Hold	—	$1.54	$1.52	-1.3%	-0.6%	+3.9%	+7.1%	+3.2%	+3.2%
May 5	Canaccord Genuity	Maintains	Hold → Hold	—	$1.14	$1.12	-1.8%	-7.0%	-7.9%	+24.6%	+8.8%	+64.0%
Mar 13	Canaccord Genuity	Maintains	Hold → Hold	—	$1.42	$1.28	-9.9%	-5.6%	-7.0%	-7.0%	-9.9%	-7.0%
Nov 13	Canaccord Genuity	Maintains	Hold → Hold	—	$1.70	$1.75	+2.9%	+8.8%	+5.3%	-10.0%	-7.6%	-4.7%
Aug 12	Canaccord Genuity	Maintains	Hold → Hold	—	$1.12	$1.11	-0.9%	+15.2%	+12.5%	+15.2%	+25.0%	+25.9%
Aug 9	Piper Sandler	Maintains	Underweight → Underweight	—	$1.29	$1.00	-22.5%	-13.2%	+0.0%	-2.3%	+0.0%	+8.5%
Jul 26	Stifel	Maintains	Hold → Hold	—	$1.82	$1.81	-0.5%	-1.6%	+2.7%	-1.1%	+1.6%	-6.6%
Jul 11	Piper Sandler	Maintains	Underweight → Underweight	—	$1.76	$1.74	-1.1%	+4.5%	+14.2%	+19.9%	+25.0%	+18.2%
May 13	TD Cowen	Maintains	Hold → Hold	—	$2.74	$2.72	-0.7%	+0.0%	+2.2%	+1.1%	+1.1%	+0.0%
May 13	DA Davidson	Maintains	Buy → Buy	—	$2.74	$2.72	-0.7%	+0.0%	+2.2%	+1.1%	+1.1%	+0.0%
May 10	Piper Sandler	Maintains	Underweight → Underweight	—	$3.59	$3.20	-10.9%	-23.7%	-23.7%	-22.0%	-22.8%	-22.8%
Mar 15	DA Davidson	Maintains	Buy → Buy	—	$3.82	$3.78	-1.0%	-5.5%	-5.5%	+3.1%	+14.1%	+16.5%
Mar 14	Canaccord Genuity	Maintains	Hold → Hold	—	$4.25	$4.22	-0.7%	-10.1%	-15.1%	-15.1%	-7.3%	+2.6%
Mar 13	TD Cowen	Maintains	Market Perform → Market Perform	—	$3.59	$4.57	+27.3%	+18.4%	+6.4%	+0.6%	+0.6%	+9.7%
Mar 13	Piper Sandler	Maintains	Underweight → Underweight	—	$3.59	$4.57	+27.3%	+18.4%	+6.4%	+0.6%	+0.6%	+9.7%
Mar 13	Stifel	Maintains	Hold → Hold	—	$3.59	$4.57	+27.3%	+18.4%	+6.4%	+0.6%	+0.6%	+9.7%
Feb 29	Canaccord Genuity	Maintains	Hold → Hold	—	$3.43	$3.54	+3.2%	-2.9%	+8.7%	+6.4%	+0.9%	+1.2%
Nov 15	Jefferies	Downgrade	Buy → Hold	—	$1.39	$1.46	+5.0%	+36.7%	+28.1%	+62.6%	+68.3%	+60.4%
Nov 14	Piper Sandler	Downgrade	Overweight → Underweight	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	JP Morgan	Downgrade	Neutral → Underweight	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	William Blair	Downgrade	Outperform → Market Perform	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	Raymond James	Downgrade	Market Perform → Underperform	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	Stifel	Maintains	Hold → Hold	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	TD Cowen	Downgrade	Outperform → Market Perform	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	Canaccord Genuity	Downgrade	Buy → Hold	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Nov 14	Benchmark	Downgrade	Buy → Hold	—	$3.90	$1.57	-59.7%	-64.4%	-51.3%	-54.4%	-42.1%	-40.0%
Sep 13	Benchmark	Maintains	Buy → Buy	—	$6.76	$6.75	-0.1%	-1.0%	-0.7%	-0.4%	-9.0%	-10.5%
Aug 10	TD Cowen	Maintains	Outperform → Outperform	—	$7.12	$7.25	+1.8%	-0.6%	-1.8%	-7.9%	-13.3%	-15.3%
Aug 10	DA Davidson	Maintains	Buy → Buy	—	$7.12	$7.25	+1.8%	-0.6%	-1.8%	-7.9%	-13.3%	-15.3%
Aug 8	Benchmark	Maintains	Buy → Buy	—	$7.63	$7.48	-2.0%	-1.3%	-6.7%	-7.2%	-8.4%	-14.0%
Jun 21	Stifel	Downgrade	Buy → Hold	—	$8.70	$7.70	-11.5%	-8.3%	-6.8%	-10.7%	-8.6%	-6.3%
May 26	JP Morgan	Maintains	Neutral → Neutral	—	$9.67	$9.42	-2.6%	-13.1%	-15.3%	-16.9%	-13.8%	-14.2%
May 18	Benchmark	Maintains	Buy → Buy	—	$10.42	$10.41	-0.1%	-2.2%	-1.7%	+0.2%	-4.0%	-8.3%
May 11	DA Davidson	Maintains	Buy → Buy	—	$10.26	$10.31	+0.5%	+4.2%	+1.8%	+7.0%	-1.7%	+1.6%
Mar 28	Canaccord Genuity	Maintains	Buy → Buy	—	$11.73	$11.64	-0.8%	-1.6%	-0.3%	+3.7%	+7.7%	+13.0%
Mar 20	Exane BNP Paribas	Upgrade	Underperform → Neutral	—	$11.31	$11.60	+2.6%	+0.8%	+9.3%	+5.1%	+4.9%	+7.1%
Mar 14	Benchmark	Maintains	Buy → Buy	—	$11.18	$11.55	+3.3%	+3.0%	+5.5%	+3.9%	+1.2%	+2.0%
Mar 1	DA Davidson	Maintains	Buy → Buy	—	$12.61	$12.91	+2.4%	-2.5%	+0.2%	+1.9%	-4.8%	-6.2%
Feb 16	Cowen & Co.	Maintains	Outperform → Outperform	—	$13.30	$12.83	-3.5%	-9.1%	-14.7%	-17.3%	-16.2%	-12.6%
Nov 23	Goldman Sachs	Maintains	Buy → Buy	—	$9.99	$10.03	+0.4%	+1.0%	-0.6%	-0.5%	+2.0%	+7.6%
Nov 9	JP Morgan	Downgrade	Overweight → Neutral	—	$10.70	$10.11	-5.5%	-21.1%	-10.8%	-7.4%	-4.7%	-2.2%
Nov 9	DA Davidson	Maintains	Buy → Buy	—	$10.70	$10.11	-5.5%	-21.1%	-10.8%	-7.4%	-4.7%	-2.2%
Sep 28	DA Davidson	Maintains	Buy → Buy	—	$11.58	$11.78	+1.7%	+10.4%	+1.8%	+1.8%	+9.2%	+15.7%
Sep 16	Piper Sandler	Maintains	Overweight → Overweight	—	$12.57	$12.71	+1.1%	-4.7%	-3.2%	-6.1%	-10.0%	-16.4%
Sep 16	DA Davidson	Maintains	Buy → Buy	—	$12.57	$12.71	+1.1%	-4.7%	-3.2%	-6.1%	-10.0%	-16.4%
Aug 16	Goldman Sachs	Maintains	Buy → Buy	—	$13.75	$13.65	-0.7%	-2.4%	-3.1%	-5.5%	-13.3%	-17.5%

Recent Filings

8-K · 5.02 !!! Very High

SkinHealth Systems Inc. -- 8-K 5.02: Executive Change

SkinHealth Systems appointed Kenneth Tripp as director and Dr. Sachin Shridharani as Senior Vice President, signaling management strengthening under new leadership.

Apr 22

8-K

Unknown — 8-K Filing

Skin Inc. achieved fourth-quarter operational improvements driving margin expansion and profitability gains, signaling successful cost management that should enhance shareholder returns and investor confidence.

Mar 12

8-K · 8.01 !! High

SkinHealth Systems Inc. -- 8-K 8.01: Material Event / Announcement

Beauty Health Company settled a consolidated stockholder derivative action in Delaware Court of Chancery, pending court approval, resolving claims related to corporate governance matters without disclosed financial terms.

Mar 6

Data updated apr 27, 2026 1:27am · Source: massive.com